XANTHINE OXIDASE ACTIVITY IN PATIENTS WITH CONGESTIVE HEART FAILURE AND CHRONIC KIDNEY DISEASE


  • M Kolomiiets Kharkiv medical academy of postgraduate education, Ukraine
  • A. Bilchenko Kharkiv medical academy of postgraduate education, Ukraine
  • K. Smolianyk Kharkiv medical academy of postgraduate education, Ukraine
Keywords: xanthine metabolism, asymptomatic hyperuricemia, xanthine oxidase activity.

Abstract

XANTHINE OXIDASE ACTIVITY IN PATIENTS WITH CONGESTIVE HEART FAILURE AND CHRONIC KIDNEY DISEASE

References

1. CerezoC. Uric Acid and Cardiovascular Risk Considered: an Update/ С. Cerezo, L. Ruilope // E-jornal of the ESC.– і2012.– Vol.10, №21.

2. Goicoechea M. Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial / M. Goicoechea, S. Garcia de Vinuesa, U. Verdalles [et al.] // Am J Kidney Dis.– 2015.– 65(4).– P. 543–549.

3. Givertz M.M, Anstrom K.J, Redfield M.M. et al. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study // Circulation. 2015 May 19;131(20):1763-71.
Published
2019-11-07
How to Cite
Kolomiiets, M., Bilchenko, A., & Smolianyk, K. (2019). XANTHINE OXIDASE ACTIVITY IN PATIENTS WITH CONGESTIVE HEART FAILURE AND CHRONIC KIDNEY DISEASE. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 3(1), 56-57. https://doi.org/10.29256/v.03.01.2019.escbm36
Section
Selected abstracts